| NDC Code | 70461-301-10 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (70461-301-10) > 5 mL in 1 VIAL, MULTI-DOSE (70461-301-12) |
|---|
| Product NDC | 70461-301 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flucelvax Quadrivalent (multi-dose Vial) |
|---|
| Non-Proprietary Name | A/singapore/gp1908/2015 Ivr-180 (h1n1) (an A/michigan/45/2015-like Virus), A/singapore/gp2050/2015 (h3n2) (an A/hong Kong/4801/2014 - Like Virus), B/utah/9/2014 (a B/phuket/3073/2013-like Virus), B/hong Kong/259/2010 (a B/brisbane/60/08-like Virus) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20170701 |
|---|
| End Marketing Date | 20180630 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125408 |
|---|
| Manufacturer | Seqirus, Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/GP2050/2015 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/HONG KONG/259/2010 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|